Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1998 Mar;77(5):801–807. doi: 10.1038/bjc.1998.130

Serum levels of soluble intercellular adhesion molecule-1 (ICAM-1, CD54) in patients with non-small-cell lung cancer: correlation with histological expression of ICAM-1 and tumour stage.

A Grothey 1, P Heistermann 1, S Philippou 1, R Voigtmann 1
PMCID: PMC2149953  PMID: 9514061

Abstract

The expression of the intercellular adhesion molecule-1 (ICAM-1, CD54) seems to have an influence on the metastatic behaviour of tumour cells via immunological mechanisms. Recently, a soluble form of ICAM-1 was identified in physiological fluids. We analysed the serum levels of sICAM-1 in patients with non-small-cell lung cancer (NSCLC) and healthy individuals using a sandwich ELISA technique. Sera from 51 patients with NSCLC were tested for sICAM-1 (46 male, five female; age 38-81 years, median 64 years), 29 of whom presented with localized and 26 with metastatic disease. The control group consisted of 40 healthy individuals (20 smokers, 20 non-smokers). Immunohistochemical analysis of ICAM-1 in tumour cells was performed in 20 cases. Patients with NSCLC had significantly higher serum levels of sICAM-1 compared with healthy non-smokers (P = 0.00001) and smokers (P= 0.0328). Metastatic disease was associated with higher sICAM-1 than localized tumours (P = 0.0013). Only 11 out of 23 patients with localized NSCLC had sICAM-1 levels >300 ng ml(-1), compared with 25 out of 28 patients with metastatic disease. Histological expression of ICAM-1 was positively correlated with serum slCAM-1 (P = 0.0399). No difference was observed between histological tumour types with regard to sICAM-1 or NSCLC expression of ICAM-1. In sequential analysis (13 patients), rising sICAM-1 levels predicted a short-term fatal outcome (P = 0.0054) but, overall, sICAM-1 levels did not correlate with prognosis. In the control group, smokers showed significantly higher levels than non-smokers (P = 0.0016). In contrast to patients with NSCLC, sICAM-1 in the control group was correlated to the leucocyte count (r = 0.580, P = 0.003). In conclusion, serum levels of sICAM-1 seem to be associated with tumour burden and histological expression of ICAM-1 in patients with NSCLC. However, the (patho-) physiological role of ICAM-1 in NSCLC remains to be determined.

Full text

PDF
801

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams D. H., Shaw S. Leucocyte-endothelial interactions and regulation of leucocyte migration. Lancet. 1994 Apr 2;343(8901):831–836. doi: 10.1016/s0140-6736(94)92029-x. [DOI] [PubMed] [Google Scholar]
  2. Altomonte M., Gloghini A., Bertola G., Gasparollo A., Carbone A., Ferrone S., Maio M. Differential expression of cell adhesion molecules CD54/CD11a and CD58/CD2 by human melanoma cells and functional role in their interaction with cytotoxic cells. Cancer Res. 1993 Jul 15;53(14):3343–3348. [PubMed] [Google Scholar]
  3. Aznavoorian S., Murphy A. N., Stetler-Stevenson W. G., Liotta L. A. Molecular aspects of tumor cell invasion and metastasis. Cancer. 1993 Feb 15;71(4):1368–1383. doi: 10.1002/1097-0142(19930215)71:4<1368::aid-cncr2820710432>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
  4. Banks R. E., Gearing A. J., Hemingway I. K., Norfolk D. R., Perren T. J., Selby P. J. Circulating intercellular adhesion molecule-1 (ICAM-1), E-selectin and vascular cell adhesion molecule-1 (VCAM-1) in human malignancies. Br J Cancer. 1993 Jul;68(1):122–124. doi: 10.1038/bjc.1993.298. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Becker J. C., Dummer R., Hartmann A. A., Burg G., Schmidt R. E. Shedding of ICAM-1 from human melanoma cell lines induced by IFN-gamma and tumor necrosis factor-alpha. Functional consequences on cell-mediated cytotoxicity. J Immunol. 1991 Dec 15;147(12):4398–4401. [PubMed] [Google Scholar]
  6. Becker J. C., Termeer C., Schmidt R. E., Bröcker E. B. Soluble intercellular adhesion molecule-1 inhibits MHC-restricted specific T cell/tumor interaction. J Immunol. 1993 Dec 15;151(12):7224–7232. [PubMed] [Google Scholar]
  7. Budnik A., Grewe M., Gyufko K., Krutmann J. Analysis of the production of soluble ICAM-1 molecules by human cells. Exp Hematol. 1996 Feb;24(2):352–359. [PubMed] [Google Scholar]
  8. Carlos T. M., Harlan J. M. Leukocyte-endothelial adhesion molecules. Blood. 1994 Oct 1;84(7):2068–2101. [PubMed] [Google Scholar]
  9. Christiansen I., Enblad G., Kälkner K. M., Gidlöf C., Glimelius B., Tötterman T. H. Soluble ICAM-1 in Hodgkin's disease: a promising independent predictive marker for survival. Leuk Lymphoma. 1995 Oct;19(3-4):243–251. doi: 10.3109/10428199509107894. [DOI] [PubMed] [Google Scholar]
  10. Christiansen I., Gidlof C., Kälkner K M., Hagberg H., Bennmarker H., Tötterman T. Elevated serum levels of soluble ICAM-1 in non-Hodgkin's lymphomas correlate with tumour burden, disease activity and other prognostic markers. Br J Haematol. 1996 Mar;92(3):639–646. doi: 10.1046/j.1365-2141.1996.00377.x. [DOI] [PubMed] [Google Scholar]
  11. Christiansen I., Gidlöf C., Wallgren A. C., Simonsson B., Tötterman T. H. Serum levels of soluble intercellular adhesion molecule 1 are increased in chronic B-lymphocytic leukemia and correlate with clinical stage and prognostic markers. Blood. 1994 Nov 1;84(9):3010–3016. [PubMed] [Google Scholar]
  12. Diamond M. S., Staunton D. E., de Fougerolles A. R., Stacker S. A., Garcia-Aguilar J., Hibbs M. L., Springer T. A. ICAM-1 (CD54): a counter-receptor for Mac-1 (CD11b/CD18). J Cell Biol. 1990 Dec;111(6 Pt 2):3129–3139. doi: 10.1083/jcb.111.6.3129. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Furukawa S., Motohashi T., Matsubara T., Imai K., Okumura K., Yabuta K. Soluble ICAM-1 levels in serum during acute infectious mononucleosis. Scand J Infect Dis. 1993;25(2):249–252. doi: 10.3109/00365549309008492. [DOI] [PubMed] [Google Scholar]
  14. Gearing A. J., Hemingway I., Pigott R., Hughes J., Rees A. J., Cashman S. J. Soluble forms of vascular adhesion molecules, E-selectin, ICAM-1, and VCAM-1: pathological significance. Ann N Y Acad Sci. 1992 Dec 4;667:324–331. doi: 10.1111/j.1749-6632.1992.tb51633.x. [DOI] [PubMed] [Google Scholar]
  15. Gearing A. J., Newman W. Circulating adhesion molecules in disease. Immunol Today. 1993 Oct;14(10):506–512. doi: 10.1016/0167-5699(93)90267-O. [DOI] [PubMed] [Google Scholar]
  16. Giavazzi R., Chirivi R. G., Garofalo A., Rambaldi A., Hemingway I., Pigott R., Gearing A. J. Soluble intercellular adhesion molecule 1 is released by human melanoma cells and is associated with tumor growth in nude mice. Cancer Res. 1992 May 1;52(9):2628–2630. [PubMed] [Google Scholar]
  17. Gruss H. J., Dölken G., Brach M. A., Mertelsmann R., Herrmann F. Serum levels of circulating ICAM-1 are increased in Hodgkin's disease. Leukemia. 1993 Aug;7(8):1245–1249. [PubMed] [Google Scholar]
  18. Harning R., Mainolfi E., Bystryn J. C., Henn M., Merluzzi V. J., Rothlein R. Serum levels of circulating intercellular adhesion molecule 1 in human malignant melanoma. Cancer Res. 1991 Sep 15;51(18):5003–5005. [PubMed] [Google Scholar]
  19. Hoffmann J. C., Krüger H., Lührs J., Hamm H. Detection of soluble adhesion molecules in pleural effusions. Chest. 1996 Jul;110(1):107–113. doi: 10.1378/chest.110.1.107. [DOI] [PubMed] [Google Scholar]
  20. Huang M., Wang J., Lee P., Sharma S., Mao J. T., Meissner H., Uyemura K., Modlin R., Wollman J., Dubinett S. M. Human non-small cell lung cancer cells express a type 2 cytokine pattern. Cancer Res. 1995 Sep 1;55(17):3847–3853. [PubMed] [Google Scholar]
  21. Hviid L., Theander T. G., Elhassan I. M., Jensen J. B. Increased plasma levels of soluble ICAM-1 and ELAM-1 (E-selectin) during acute Plasmodium falciparum malaria. Immunol Lett. 1993 Apr;36(1):51–58. doi: 10.1016/0165-2478(93)90068-d. [DOI] [PubMed] [Google Scholar]
  22. Klein B., Levin I., Kfir B., Mishaeli M., Shapira J., Klein T. The significance of soluble interleukin-2, soluble interleukin-2 receptors, soluble ICAM-1 and beta 2-microglobulin in breast cancer patients. Tumour Biol. 1995;16(5):290–296. [PubMed] [Google Scholar]
  23. Kobayashi T., Hashimoto S., Imai K., Amemiya E., Yamaguchi M., Yachi A., Horie T. Elevation of serum soluble intercellular adhesion molecule-1 (sICAM-1) and sE-selectin levels in bronchial asthma. Clin Exp Immunol. 1994 Apr;96(1):110–115. doi: 10.1111/j.1365-2249.1994.tb06239.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Lowe G. D., Machado S. G., Krol W. F., Barton B. A., Forbes C. D. White blood cell count and haematocrit as predictors of coronary recurrence after myocardial infarction. Thromb Haemost. 1985 Oct 30;54(3):700–703. [PubMed] [Google Scholar]
  25. Mackay C. R., Imhof B. A. Cell adhesion in the immune system. Immunol Today. 1993 Mar;14(3):99–102. doi: 10.1016/0167-5699(93)90205-Y. [DOI] [PubMed] [Google Scholar]
  26. Martin S., Martin A., Staunton D. E., Springer T. A. Functional studies of truncated soluble intercellular adhesion molecule 1 expressed in Escherichia coli. Antimicrob Agents Chemother. 1993 Jun;37(6):1278–1284. doi: 10.1128/aac.37.6.1278. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Meyer D. M., Dustin M. L., Carron C. P. Characterization of intercellular adhesion molecule-1 ectodomain (sICAM-1) as an inhibitor of lymphocyte function-associated molecule-1 interaction with ICAM-1. J Immunol. 1995 Oct 1;155(7):3578–3584. [PubMed] [Google Scholar]
  28. Mrowka C., Sieberth H. G. Circulating adhesion molecules ICAM-1, VCAM-1 and E-selectin in systemic vasculitis: marked differences between Wegener's granulomatosis and systemic lupus erythematosus. Clin Investig. 1994 Oct;72(10):762–768. doi: 10.1007/BF00180543. [DOI] [PubMed] [Google Scholar]
  29. Pandolfi F., Trentin L., Boyle L. A., Stamenkovic I., Byers H. R., Colvin R. B., Kurnick J. T. Expression of cell adhesion molecules in human melanoma cell lines and their role in cytotoxicity mediated by tumor-infiltrating lymphocytes. Cancer. 1992 Mar 1;69(5):1165–1173. doi: 10.1002/cncr.2820690517. [DOI] [PubMed] [Google Scholar]
  30. Passlick B., Izbicki J. R., Simmel S., Kubuschok B., Karg O., Habekost M., Thetter O., Schweiberer L., Pantel K. Expression of major histocompatibility class I and class II antigens and intercellular adhesion molecule-1 on operable non-small cell lung carcinomas: frequency and prognostic significance. Eur J Cancer. 1994;30A(3):376–381. doi: 10.1016/0959-8049(94)90259-3. [DOI] [PubMed] [Google Scholar]
  31. Patel R. T., Pall A. A., Adu D., Keighley M. R. Circulating soluble adhesion molecules in inflammatory bowel disease. Eur J Gastroenterol Hepatol. 1995 Nov;7(11):1037–1041. doi: 10.1097/00042737-199511000-00005. [DOI] [PubMed] [Google Scholar]
  32. Rieckmann P., Michel U., Albrecht M., Brück W., Wöckel L., Felgenhauer K. Soluble forms of intercellular adhesion molecule-1 (ICAM-1) block lymphocyte attachment to cerebral endothelial cells. J Neuroimmunol. 1995 Jul;60(1-2):9–15. doi: 10.1016/0165-5728(95)00047-6. [DOI] [PubMed] [Google Scholar]
  33. Roep B. O., Heidenthal E., de Vries R. R., Kolb H., Martin S. Soluble forms of intercellular adhesion molecule-1 in insulin-dependent diabetes mellitus. Lancet. 1994 Jun 25;343(8913):1590–1593. doi: 10.1016/s0140-6736(94)93055-4. [DOI] [PubMed] [Google Scholar]
  34. Rothlein R., Mainolfi E. A., Czajkowski M., Marlin S. D. A form of circulating ICAM-1 in human serum. J Immunol. 1991 Dec 1;147(11):3788–3793. [PubMed] [Google Scholar]
  35. Santarosa M., Favaro D., Quaia M., Spada A., Sacco C., Talamini R., Galligioni E. Expression and release of intercellular adhesion molecule-1 in renal-cancer patients. Int J Cancer. 1995 Jul 28;62(3):271–275. doi: 10.1002/ijc.2910620307. [DOI] [PubMed] [Google Scholar]
  36. Schardt C., Heymanns J., Schardt C., Rotsch M., Havemann K. Differential expression of the intercellular adhesion molecule-1 (ICAM-1) in lung cancer cell lines of various histological types. Eur J Cancer. 1993;29A(16):2250–2255. doi: 10.1016/0959-8049(93)90217-4. [DOI] [PubMed] [Google Scholar]
  37. Schwartz J., Weiss S. T. Cigarette smoking and peripheral blood leukocyte differentials. Ann Epidemiol. 1994 May;4(3):236–242. doi: 10.1016/1047-2797(94)90102-3. [DOI] [PubMed] [Google Scholar]
  38. Seth R., Raymond F. D., Makgoba M. W. Circulating ICAM-1 isoforms: diagnostic prospects for inflammatory and immune disorders. Lancet. 1991 Jul 13;338(8759):83–84. doi: 10.1016/0140-6736(91)90077-3. [DOI] [PubMed] [Google Scholar]
  39. Sharief M. K., Noori M. A., Ciardi M., Cirelli A., Thompson E. J. Increased levels of circulating ICAM-1 in serum and cerebrospinal fluid of patients with active multiple sclerosis. Correlation with TNF-alpha and blood-brain barrier damage. J Neuroimmunol. 1993 Mar;43(1-2):15–21. doi: 10.1016/0165-5728(93)90070-f. [DOI] [PubMed] [Google Scholar]
  40. Shijubo N., Imai K., Shigehara K., Hirasawa M., Tsujisaki M., Hinoda Y., Abe S. Soluble intercellular adhesion molecule-1 (ICAM-1) in sera and bronchoalveolar lavage (BAL) fluids of extrinsic allergic alveolitis. Clin Exp Immunol. 1995 Oct;102(1):91–97. doi: 10.1111/j.1365-2249.1995.tb06641.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Springer T. A. Adhesion receptors of the immune system. Nature. 1990 Aug 2;346(6283):425–434. doi: 10.1038/346425a0. [DOI] [PubMed] [Google Scholar]
  42. Tsujisaki M., Imai K., Hirata H., Hanzawa Y., Masuya J., Nakano T., Sugiyama T., Matsui M., Hinoda Y., Yachi A. Detection of circulating intercellular adhesion molecule-1 antigen in malignant diseases. Clin Exp Immunol. 1991 Jul;85(1):3–8. doi: 10.1111/j.1365-2249.1991.tb05673.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Tsukada N., Miyagi K., Matsuda M., Yanagisawa N. Increased levels of circulating intercellular adhesion molecule-1 in multiple sclerosis and human T-lymphotropic virus type I-associated myelopathy. Ann Neurol. 1993 Jun;33(6):646–649. doi: 10.1002/ana.410330614. [DOI] [PubMed] [Google Scholar]
  44. Welder C. A., Lee D. H., Takei F. Inhibition of cell adhesion by microspheres coated with recombinant soluble intercellular adhesion molecule-1. J Immunol. 1993 Mar 15;150(6):2203–2210. [PubMed] [Google Scholar]
  45. Woska J. R., Jr, Morelock M. M., Jeanfavre D. D., Bormann B. J. Characterization of molecular interactions between intercellular adhesion molecule-1 and leukocyte function- associated antigen-1. J Immunol. 1996 Jun 15;156(12):4680–4685. [PubMed] [Google Scholar]
  46. Zöhrens G., Armbrust T., Pirzer U., Meyer zum Büschenfelde K. H., Ramadori G. Intercellular adhesion molecule-1 concentration in sera of patients with acute and chronic liver disease: relationship to disease activity and cirrhosis. Hepatology. 1993 Oct;18(4):798–802. doi: 10.1002/hep.1840180408. [DOI] [PubMed] [Google Scholar]
  47. van de Stolpe A., van der Saag P. T. Intercellular adhesion molecule-1. J Mol Med (Berl) 1996 Jan;74(1):13–33. doi: 10.1007/BF00202069. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES